The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Goniotaire
Hypromellose 2906 (4000 Mpa.s) · HYPROMELLOSE 2906 (4000 MPA.S) 25 mg/mL · Solution · Ophthalmic · Altaire Pharmaceuticals Inc.
NDC 59390-0182-13 · 1 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for hypromellose (other) in the next 90 days
4 Class I/II recall(s) in 12 months · sole-source market · price up 8% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · CompletedJul 2, 2019Altaire Pharmaceuticals, Inc. — Lack of Assurance of Sterility
Manufacturers of Hypromellose 2906 (4000 Mpa.s) (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Altaire Pharmaceuticals Inc. | HYPROMELLOSE 2906 (4000 MPA.S) 25 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Goniotaire — NDC 59390-0182-13," retrieved September 3, 2026, https://drugdashboards.com/drug/59390018213.
Free to cite with attribution — see how the data is put together.